ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6068
-0.44%
Brent Oil
83.76
0.67%
Bitcoin
66,881.83
2.52%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. CSE
  6. Lexaria Bioscience Corp (LXX)

  7. Lexaria Bioscience Corp (LXX) Noticias

LXX

Lexaria Bioscience (LXX)

Lexaria Bioscience Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:CSE:LXX
FechaHoraFuenteTítuloSímboloCompañía
20/05/202106:16InvestorsHub NewsWireLexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..contCSE:LXXLexaria Bioscience Corp
22/04/202106:30InvestorsHub NewsWireLexaria Commences Human Clinical Hypertension StudyCSE:LXXLexaria Bioscience Corp
14/04/202106:37InvestorsHub NewsWireLexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope NetworkCSE:LXXLexaria Bioscience Corp
06/04/202106:16InvestorsHub NewsWireLexaria to Evaluate DehydraTECHTM in Multiple New MarketsCSE:LXXLexaria Bioscience Corp
24/03/202107:00InvestorsHub NewsWireLexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD BeveragesCSE:LXXLexaria Bioscience Corp
10/03/202110:54InvestorsHub NewsWireCould DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria?CSE:LXXLexaria Bioscience Corp
27/01/202107:00InvestorsHub NewsWireCANNABIS INVESTING - Khiron (KHRNF) & Lexaria (LEXX) with Ted OhashiCSE:LXXLexaria Bioscience Corp
16/12/202009:00InvestorsHub NewsWireCANNABIS INVESTING - Cannabis News, Khiron, & Lexaria BioscienceCSE:LXXLexaria Bioscience Corp
01/12/202005:41InvestorsHub NewsWireLexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral DrugsCSE:LXXLexaria Bioscience Corp
04/09/201907:45InvestorWireInnovative Drug-Delivery Systems Benefit Patients and BusinessesCSE:LXXLexaria Bioscience Corp
11/06/201907:45InvestorWireDramatically Improved Delivery Systems Promise More Effective Cannabis TreatmentsCSE:LXXLexaria Bioscience Corp
29/05/201907:45InvestorWireDisruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, EdiblesCSE:LXXLexaria Bioscience Corp
30/01/201907:45InvestorWireOutside Investment, New Technology Support Growing Cannabis IndustryCSE:LXXLexaria Bioscience Corp
16/01/201907:45InvestorWireDefinitive Agreement Marks Milestone for Alternative Nicotine Delivery OptionsCSE:LXXLexaria Bioscience Corp
28/11/201807:45InvestorWireBooming Cannabis Consumables Space Continues to see Product InnovationsCSE:LXXLexaria Bioscience Corp
22/10/201807:45InvestorWireCanada Leads International Cannabis Boom — and It’s Not About SmokingCSE:LXXLexaria Bioscience Corp
04/10/201807:45InvestorWireIntangible Assets Power Growth, Acquisitions in the Pharmaceuticals SectorCSE:LXXLexaria Bioscience Corp
15/08/201807:45InvestorWireBig Businesses Look for Healthier Alternatives to Smoking for Drug DeliveryCSE:LXXLexaria Bioscience Corp
24/04/201807:45InvestorWireInnovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech SectorsCSE:LXXLexaria Bioscience Corp
03/04/201807:45InvestorWireCannabis Biotech BoomsCSE:LXXLexaria Bioscience Corp
06/02/201807:45InvestorWireCannabis Deals Cross the Billion-Dollar Mark in CanadaCSE:LXXLexaria Bioscience Corp
09/01/201807:45InvestorWireIntriguing Research into Pathways to Limit Nicotine, Quit Cigarette UseCSE:LXXLexaria Bioscience Corp
09/11/201709:12InvestorsHub NewsWireLexaria Bioscience Files Innovative New Patent ApplicationCSE:LXXLexaria Bioscience Corp
02/11/201707:45InvestorWireBioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, MedicationCSE:LXXLexaria Bioscience Corp
01/11/201708:32InvestorsHub NewsWireLexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, and Nicotine ...CSE:LXXLexaria Bioscience Corp
19/09/201707:45InvestorWireAdvances in Drug Delivery Hold the Promise of Reducing Inevitable Side EffectsCSE:LXXLexaria Bioscience Corp
06/09/201707:45InvestorWireLandmark M&A Deals Continue to Shape Big PharmaCSE:LXXLexaria Bioscience Corp
16/08/201707:45InvestorWireFDA Proposal Puts Spotlight on Big Tobacco and Industry InnovatorsCSE:LXXLexaria Bioscience Corp
27/07/201707:45InvestorWireBiotech Players Lead the Growth Charge in the Legal Cannabis MarketCSE:LXXLexaria Bioscience Corp
19/01/201708:11InvestorsHub NewsWireLEXARIA AND NEUTRISCI ANNOUNCE SUCCESSFUL CANNABINOID TABLET DEVELOPMENT AND POSITIVE RESULTSCSE:LXXLexaria Bioscience Corp
 Showing the most relevant articles for your search:CSE:LXX

Su Consulta Reciente

GATE
XYUSDT
XY Token
LSE
94IU
Nestle Fin 24
NASDAQ
FARQX
Franklin Conservative Al...
ASX
ANPDA
BIBX
MSHOOBTC
Shoot
ASX
S32BOR
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados